Please provide your email address to receive an email when new articles are posted on . Histologic outcomes were similar regardless of whether budesonide-treated patients underwent dilation. More ...
Treatment with dupilumab demonstrated improvements in histological markers, symptoms, and endoscopic markers of eosinophilic esophagitis (EoE) regardless of previous history of esophageal dilation. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results